"However, true success is measured by health outcomes, not appearance
At this point, allulose isnt widely used in commercial products, and its pricier than other sweeteners, says Frank Hu, MD, PhD, a professor of nutrition and epidemiology and the chair of the department of nutrition at the Harvard T.H
This article explores early warning Read More Incretin Therapy Selection in High-Risk Patients: What New Outcomes Data Suggest May 4, 2026 Articles, Cardiology, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 903 views Choosing the right treatment for patients with both diabetes and heart disease can feel like walking a tightrope
Si lo necesita
What is the status of intravenous injections or infusions as part of a medical procedure